• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二吡啶基取代的硫代缩氨基脲作为一种有效的广谱金属-β-内酰胺酶抑制剂。

Dipyridyl-substituted thiosemicarbazone as a potent broad-spectrum inhibitor of metallo-β-lactamases.

机构信息

Key Laboratory of Synthetic and Natural Functional Molecule of the Ministry of Education, College of Chemistry and Materials Science, Northwest University, Xi'an 710127, PR China.

Shaanxi Key Laboratory of Phytochemistry, College of Chemistry and Chemical Engineering, Baoji University of Arts and Sciences, Baoji 72101, Shaanxi Province, PR China.

出版信息

Bioorg Med Chem. 2021 May 15;38:116128. doi: 10.1016/j.bmc.2021.116128. Epub 2021 Apr 8.

DOI:10.1016/j.bmc.2021.116128
PMID:33862468
Abstract

To combat the superbug infection caused by metallo-β-lactamases (MβLs), a dipyridyl-substituted thiosemicarbazone (DpC), was identified to be the broad-spectrum inhibitor of MβLs (NDM-1, VIM-2, IMP-1, ImiS, L1), with an IC value in the range of 0.021-1.08 µM. It reversibly and competitively inhibited NDM-1 with a K value of 10.2 nM. DpC showed broad-spectrum antibacterial effect on clinical isolate K. pneumonia, CRE, VRE, CRPA and MRSA, with MIC value ranged from 16 to 32 µg/mL, and exhibited synergistic antibacterial effect with meropenem on MβLs-producing bacteria, resulting in a 2-16-, 2-8-, and 8-fold reduction in MIC of meropenem against EC-MβLs, EC01-EC24, K. pneumonia, respectively. Moreover, mice experiments showed that DpC also had synergistic antibacterial action with meropenem. In this work, DpC was identified to be a potent scaffold for the development of broad-spectrum inhibitors of MβLs.

摘要

为了对抗金属β-内酰胺酶(MβLs)引起的超级细菌感染,我们鉴定出一种双吡啶取代的硫代缩氨基脲(DpC),它是 MβLs(NDM-1、VIM-2、IMP-1、ImiS、L1)的广谱抑制剂,其 IC 值在 0.021-1.08µM 范围内。它以 10.2nM 的 K 值可逆且竞争性地抑制 NDM-1。DpC 对临床分离的肺炎克雷伯菌、CRE、VRE、CRPA 和 MRSA 具有广谱的抗菌作用,其 MIC 值范围为 16 至 32µg/mL,与美罗培南联合使用对产 MβLs 的细菌具有协同抗菌作用,使美罗培南对 EC-MβLs、EC01-EC24、肺炎克雷伯菌的 MIC 值分别降低了 2-16 倍、2-8 倍和 8 倍。此外,小鼠实验表明,DpC 与美罗培南也具有协同抗菌作用。在这项工作中,DpC 被鉴定为开发 MβLs 广谱抑制剂的有效支架。

相似文献

1
Dipyridyl-substituted thiosemicarbazone as a potent broad-spectrum inhibitor of metallo-β-lactamases.二吡啶基取代的硫代缩氨基脲作为一种有效的广谱金属-β-内酰胺酶抑制剂。
Bioorg Med Chem. 2021 May 15;38:116128. doi: 10.1016/j.bmc.2021.116128. Epub 2021 Apr 8.
2
Dihydroxyphenyl-substituted thiosemicarbazone: A potent scaffold for the development of metallo-β-lactamases inhibitors and antimicrobial.二羟基苯基取代的硫代半卡巴腙:一种用于开发金属β-内酰胺酶抑制剂和抗菌剂的有效骨架。
Bioorg Chem. 2022 Oct;127:105928. doi: 10.1016/j.bioorg.2022.105928. Epub 2022 Jun 13.
3
Diaryl-substituted thiosemicarbazone: A potent scaffold for the development of New Delhi metallo-β-lactamase-1 inhibitors.二芳基取代的硫代缩氨基脲:开发新型德里金属β-内酰胺酶-1 抑制剂的有效支架。
Bioorg Chem. 2021 Feb;107:104576. doi: 10.1016/j.bioorg.2020.104576. Epub 2020 Dec 22.
4
Thiosemicarbazones exhibit inhibitory efficacy against New Delhi metallo-β-lactamase-1 (NDM-1).硫代卡巴肼对新德里金属β-内酰胺酶 1(NDM-1)具有抑制作用。
J Antibiot (Tokyo). 2021 Sep;74(9):574-579. doi: 10.1038/s41429-021-00440-3. Epub 2021 Jul 7.
5
The assemblage of covalent and metal binding dual functional scaffold for cross-class metallo-β-lactamases inhibition.用于交叉类金属β-内酰胺酶抑制的共价和金属结合双重功能支架的组装。
Future Med Chem. 2019 Sep;11(18):2381-2394. doi: 10.4155/fmc-2019-0008. Epub 2019 Sep 23.
6
Hydroxamic acid with benzenesulfonamide: An effective scaffold for the development of broad-spectrum metallo-β-lactamase inhibitors.羟肟酸与苯磺酰胺:开发广谱金属β-内酰胺酶抑制剂的有效支架。
Bioorg Chem. 2020 Dec;105:104436. doi: 10.1016/j.bioorg.2020.104436. Epub 2020 Oct 29.
7
Azolylthioacetamides as a potent scaffold for the development of metallo-β-lactamase inhibitors.唑硫基乙酰胺作为开发金属β-内酰胺酶抑制剂的有效骨架。
Bioorg Med Chem Lett. 2017 Dec 1;27(23):5225-5229. doi: 10.1016/j.bmcl.2017.10.038. Epub 2017 Oct 20.
8
Discovery of hydroxamate as a promising scaffold dually inhibiting metallo- and serine-β-lactamases.发现羟肟酸是一种有前景的支架,能够双重抑制金属酶和丝氨酸β-内酰胺酶。
Eur J Med Chem. 2024 Feb 5;265:116055. doi: 10.1016/j.ejmech.2023.116055. Epub 2023 Dec 16.
9
N-acylhydrazones confer inhibitory efficacy against New Delhi metallo-β-lactamase-1.N-酰腙类化合物对新德里金属β-内酰胺酶-1 具有抑制作用。
Bioorg Chem. 2021 Sep;114:105138. doi: 10.1016/j.bioorg.2021.105138. Epub 2021 Jun 30.
10
Targeting clinically-relevant metallo-β-lactamases: from high-throughput docking to broad-spectrum inhibitors.靶向临床相关金属β-内酰胺酶:从高通量对接至广谱抑制剂
J Enzyme Inhib Med Chem. 2016;31(sup1):98-109. doi: 10.3109/14756366.2016.1172575. Epub 2016 Apr 28.

引用本文的文献

1
Breakthrough Advances in Beta-Lactamase Inhibitors: New Synthesized Compounds and Mechanisms of Action Against Drug-Resistant Bacteria.β-内酰胺酶抑制剂的突破性进展:新合成化合物及抗耐药菌作用机制
Pharmaceuticals (Basel). 2025 Feb 3;18(2):206. doi: 10.3390/ph18020206.
2
Drug Discovery in the Field of β-Lactams: An Academic Perspective.β-内酰胺类药物研发:学术视角
Antibiotics (Basel). 2024 Jan 8;13(1):59. doi: 10.3390/antibiotics13010059.
3
Small-molecule inhibitors of bacterial-producing metallo-β-lactamases: insights into their resistance mechanisms and biochemical analyses of their activities.
细菌产生的金属β-内酰胺酶的小分子抑制剂:对其耐药机制的深入了解及其活性的生化分析
RSC Med Chem. 2023 Mar 31;14(6):1012-1048. doi: 10.1039/d3md00036b. eCollection 2023 Jun 22.
4
β-Lactam potentiators to re-sensitize resistant pathogens: Discovery, development, clinical use and the way forward.β-内酰胺增效剂使耐药病原体重新敏感:发现、开发、临床应用及未来方向
Front Microbiol. 2023 Mar 10;13:1092556. doi: 10.3389/fmicb.2022.1092556. eCollection 2022.
5
Towards combating antibiotic resistance by exploring the quantitative structure-activity relationship of NDM-1 inhibitors.通过探索NDM-1抑制剂的定量构效关系来对抗抗生素耐药性。
EXCLI J. 2022 Nov 16;21:1331-1351. doi: 10.17179/excli2022-5380. eCollection 2022.